Microsens Biotechnologies is a scientific research, development and technology licensing company founded in 1998 to develop, initially, synthetic ligand-based diagnostics for the rapid and sensitive detection of Transmlssible Spongiform Encephalopathies (TSEs) and other related protein aggregation diseases, such as Alzheimer's Disease and Parkinson's Disease - collectively known as the "Protein Conformation Disorders", or the “Protein Aggregation Diseases”.